根据欧盟委员会第396/2005号法规第12章，欧盟食品安全局审查了环唑醇的最大残留限量。尽管没有发现环唑醇对消费者有明显的风险，但缺少监管框架要求的某些信息。因此，消费者风险评估仅被认为是指示性的，EFSA提出的所有MRL建议仍需风险管理者进一步考虑。

 

　　部分原文报道如下：

 

　　According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance cyproconazole. Considering that no application was received to support the renewal of the approval of cyproconazole and considering the expiry date for its approval on 31 May 2021, and that the import tolerances identified were not supported by sufficient data, and are not forming the basis of any existing EU MRLs, but correspond to existing MRLs established by the Codex Alimentarius Commission (codex maximum residue limits; CXLs), the current assessment is limited to CXLs. To assess the occurrence of cyproconazole residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008, as well as the MRLs established by the Codex Alimentarius Commission. based on the assessment of the available data, EFSA assessed the CXLs and a consumer risk assessment was carried out. Although no apparent risk to consumers was identified, some information required by the regulatory framework was missing. Hence, the consumer risk assessment is considered indicative only and all MRL proposals derived by EFSA still require further consideration by risk managers.

 

　　本文由食品伙伴网食品资讯中心编辑，有任何疑问，请联系news@www.sqrdapp.com。